Power Law company profile

Nanobiotix

Biotech & Life Sciences · Paris, France · Founded 2003 · IPO 2012 Unicorn

Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell

Valuation

$1.65B

Market cap · Apr/2026

Revenue

$33M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

4 investors on Nanobiotix's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Karista

Series B+ 3 investors entered at this stage

Crédit Mutuel Equity

OTC Asset Management

Seventure Partners

Global footprint

Where Nanobiotix has talent and traffic

AI talent share

1.4% of workforce is AI talent
(2 of 143 staff)

Core AI10.7%

Other AI10.7%

Non-AI workforce14198.6%

Workforce by country

7 countries with
team presence

🇫🇷 France88.7%

🇺🇸 United States7.6%

🇦🇪 United Arab Emirates0.9%

🇵🇱 Poland0.9%

🇨🇭 Switzerland0.9%

Top 5 of 7 shown

Web traffic by country

12K monthly visits
across markets

🇫🇷 France30%

🇺🇸 United States30%

🇵🇭 Philippines28.3%

🇩🇪 Germany8.3%

🇮🇳 India5%

Top 5 markets shown

Patent intelligence

$95M patent portfolio · 36 active families

Estimated portfolio value

$95M

5.8% of market cap · 8.2× smaller than top peer BioNTech ($780M)

36 active patent families

Where Nanobiotix innovates Biocompatible nanoparticlesPharmaceutical drugBiological organismBiocompatibilityNanoparticle

Where Nanobiotix concentrates vs peers

Each axis is a top-10 topic across Nanobiotix and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Nanobiotix

An AI-synthesized read of the highest-engagement posts about Nanobiotix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nanobiotix on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles